Cargando…
Critical Evaluation of Molecular Monitoring in Malaria Drug Efficacy Trials and Pitfalls of Length-Polymorphic Markers
Estimation of drug efficacy in antimalarial drug trials requires parasite genotyping to distinguish new infections from treatment failures. When using length-polymorphic molecular markers, preferential amplification of short fragments can compromise detection of coinfections, potentially leading to...
Autores principales: | Messerli, Camilla, Hofmann, Natalie E., Beck, Hans-Peter, Felger, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192142/ https://www.ncbi.nlm.nih.gov/pubmed/27821442 http://dx.doi.org/10.1128/AAC.01500-16 |
Ejemplares similares
-
Should Deep-Sequenced Amplicons Become the New Gold Standard for Analyzing Malaria Drug Clinical Trials?
por: Jones, Sam, et al.
Publicado: (2021) -
Targeted Amplicon Deep Sequencing for Monitoring Antimalarial Resistance Markers in Western Kenya
por: Osoti, Victor, et al.
Publicado: (2022) -
K13 Propeller Mutations in Plasmodium falciparum Populations in Regions of Malaria Endemicity in Vietnam from 2009 to 2016
por: Thuy-Nhien, Nguyen, et al.
Publicado: (2017) -
Significant Efficacy of a Single Low Dose of Primaquine Compared to Stand-Alone Artemisinin Combination Therapy in Reducing Gametocyte Carriage in Cambodian Patients with Uncomplicated Multidrug-Resistant Plasmodium falciparum Malaria
por: Vantaux, Amélie, et al.
Publicado: (2020) -
Absence of K13 Polymorphism in Plasmodium falciparum from Brazilian Areas Where the Parasite Is Endemic
por: Gomes, Larissa Rodrigues, et al.
Publicado: (2018)